If you own a Collie, an Australian Shepherd, a Border Collie, a Sheltie or any mix with herding-breed blood, there is one piece of genetic information that should exist before the first prescription is ever written: the MDR1 status. A single deletion mutation in the ABCB1 gene disables a protein pump called P-glycoprotein, whose job is to keep certain drugs out of the brain. Dogs with two copies of the mutation can suffer severe, sometimes fatal, neurotoxicity from doses of ordinary medications that other dogs shrug off. It is the most consequential single-gene result in companion-animal medicine — and a cheek swab settles it.
I say this with some force because I live it: my household is herding dogs. Border Collies and Australian Shepherds, the exact demographic this mutation was built around. For the clinical detail — the drug list, the toxicity signs, the emergency protocol — the veterinary reference at ivermectin-sensitivity.org is where I send owners, because this is one case where the reference material should come from toxicology, not folklore. The VCA's clinical summary of the MDR1 mutation covers the testing logic and the drug classes involved.
What the Mutation Actually Does
P-glycoprotein sits in the cells lining the blood-brain barrier and pumps drug molecules back out of the brain before they can accumulate. The MDR1 mutation — a four-base-pair deletion — truncates the protein so the pump never forms. The result is not a disease in itself; it is a missing safety guard. Drugs that are normally excluded from the central nervous system can cross, concentrate, and cause tremors, disorientation, seizures, coma or death.
The classic offender is ivermectin at high doses — which is how the mutation was discovered, when Collies started dying on routine deworming doses decades ago. But the clinically relevant list is longer than the name suggests: certain opioids and sedatives, loperamide (the common anti-diarrheal), some chemotherapy agents and other drugs that rely on P-glycoprotein for exclusion. The everyday danger is not exotic medication; it is the ordinary drug prescribed at an ordinary dose to a dog whose barrier quietly does not work.
Transmission: One Copy Is Not Nothing
MDR1 inheritance is autosomal — one copy from each parent — but it is not cleanly recessive. A dog with two mutant copies is fully affected and at highest risk. A heterozygote, with one normal and one mutant copy, has a partially functional pump: lower risk, but demonstrably more sensitive to the problem drugs than a clear dog. That middle state is the part most owners never hear about, and it matters — "carrier" in the PRA sense means invisible and clinically irrelevant, while "one copy" in the MDR1 sense means "dose-adjust and flag the chart."
| Genotype | P-glycoprotein function | Clinical meaning |
|---|---|---|
| Normal / Normal | Full | Standard drug handling; no flag needed |
| Normal / Mutant | Partial | Increased sensitivity — dose caution on listed drugs, flag in the record |
| Mutant / Mutant | Absent | High risk — listed drugs avoided or strictly managed by the veterinarian |
Which Breeds Carry It
The mutation concentrates in the collie family tree: Collies (roughly 70 percent carry at least one copy in sampled populations), Australian Shepherds (approaching half), Shetland Sheepdogs, Border Collies (lower but present), Old English Sheepdogs, and a scatter of herding-adjacent breeds like the English Shepherd, McNab and White Shepherd lines. Mixed breeds with herding ancestry carry it too — the DNA does not check the pedigree papers before expressing itself.
That last point matters more every year as rescue mixes proliferate. A shelter dog with collie ears and an unknown file gets the same question a show prospect gets: swab first, prescribe second. The test is cheap relative to the risk — a single swab, a permanent answer, and the kind of fact about a dog you want in the chart before an emergency rather than discovered during one.
What MDR1 Means for the Medicine Cabinet
For a mutant/mutant dog, the rules are concrete. High-dose ivermectin and related macrocyclic lactones are off the table — though it is worth noting that the tiny ivermectin doses in monthly heartworm preventives are generally considered below the neurotoxic threshold, a distinction your vet should make explicitly rather than leave to folklore. Loperamide is out. Sedation protocols get modified. Certain anti-cancer and anti-nausea drugs get dose-checked. The word "generally" is doing real work in that list — which is why the flag belongs in the medical record, not in your memory.
For a heterozygote, the posture is caution rather than prohibition: the pump works partially, doses get adjusted, and the vet knows. For a clear dog, the result is simply useful — one fewer variable in every future prescription.
And for owners managing a long-term protocol — an arthritic senior on NSAIDs, a dog on a joint supplement stack plus occasional sedation for procedures — the MDR1 status sits quietly underneath all of it. It does not change the joint plan; it changes which drugs can safely ride alongside it.
The Bottom Line
MDR1 is the rare genetic result that is simultaneously cheap, definitive and clinically urgent: a cheek swab, a three-state answer, and a flag that can prevent a fatal drug reaction in a dog that looks perfectly healthy. If your dog has herding-breed ancestry and no test result on file, that is the first gap to close — before the joint protocol, before the dental, before anything that needs a prescription. The drug lists and emergency guidance live at ivermectin-sensitivity.org; bring the result to your vet and let it live in the chart where it belongs.